Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jan;15(1):136-41.
doi: 10.1158/1535-7163.MCT-15-0409. Epub 2015 Nov 19.

Translation Inhibition by Rocaglates Is Independent of eIF4E Phosphorylation Status

Affiliations

Translation Inhibition by Rocaglates Is Independent of eIF4E Phosphorylation Status

Jennifer Chu et al. Mol Cancer Ther. 2016 Jan.

Abstract

Rocaglates are natural products that inhibit protein synthesis in eukaryotes and exhibit antineoplastic activity. In vitro biochemical assays, affinity chromatography experiments coupled with mass spectrometry analysis, and in vivo genetic screens have identified eukaryotic initiation factor (eIF) 4A as a direct molecular target of rocaglates. eIF4A is the RNA helicase subunit of eIF4F, a complex that mediates cap-dependent ribosome recruitment to mRNA templates. The eIF4F complex has been implicated in tumor initiation and maintenance through elevated levels or increased phosphorylation status of its cap-binding subunit, eIF4E, thus furthering the interest toward developing rocaglates as antineoplastic agents. Recent experiments have indicated that rocaglates also interact with prohibitins 1 and 2, proteins implicated in c-Raf-MEK-ERK signaling. Because increased ERK signaling stimulates eIF4E phosphorylation status, rocaglates are also expected to inhibit eIF4E phosphorylation status, a point that has not been thoroughly investigated. It is currently unknown whether the effects on translation observed with rocaglates are solely through eIF4A inhibition or also a feature of blocking eIF4E phosphorylation. Here, we show that rocaglates inhibit translation through an eIF4E phosphorylation-independent mechanism.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A. Proposed mechanism of action of rocaglates on eIF4A recycling through the eIF4F complex. In this model, rocaglates stimulate eIF4A RNA binding, rendering it unavailable to enter into the eIF4F complex. B. Structures of rocaglates used in this study. C. Dose-dependent inhibition of translation by rocaglates in Jurkat and NIH/3T3 cells. Cells were incubated in the presence of compound for a total of 2 hours and protein synthesis rates were determined as described in the Materials and Methods. The relative rates are of translation are calculated by normalizing to DMSO. n = 4; error bars represent the error of the mean.
Figure 2
Figure 2
A. Effects of rocaglates on eIF4E phosphorylation in Jurkat cells. Cells were incubated in the presence of the indicated compounds for 2 hours, lysed, fractionated on a 10% NuPAGE Bis-Tris gel, and transferred to PVDF membranes for western blotting. Blots were probed using antibodies directed to the proteins indicated to the right of the panel. B. Effects of rocaglates on eIF4E phosphorylation status in NIH/3T3 cells. Cells were treated, proteins fractionated, transferred to PVDF membranes, and western blots analyzed as described for Panel A. C. Effects of rocaglates on eIF4E phosphorylation status in RAS-transformed NIH/3T3 cells. Cells were treated, proteins fractionated, transferred to PVDF membranes, and western blots analyzed as described for Panel A. The dashed line indicates that probing for eIF4E and ERK were performed on different membranes. GAPDH levels were used as an internal standard to account for variations in extract levels between lanes. D. Stimulation of eIF4A:RNA binding by rocaglates. Recombinant eIF4A (1.3 μM) was incubated with 35 000 cpm of 32P-labelled RNA in the presence of 5 μM rocaglate and processed as described in the Materials and Methods. eIF4A:RNA complexes retained on nitrocellulose filters were quantitated by scintillation counting. N = 3; error bars represent error of the mean.
Figure 3
Figure 3
A. Rocaglates inhibit translation in Mnk1+/+Mnk2+/+ and Mnk1−/−Mnk2−/− MEFs. Protein synthesis rates were determined as described in the Materials and Methods. The relative rates of 35S-Met incorporation are normalized to DMSO. N = 4; error bars represent error of the mean. *, p < 0.001 (Student's t-test). B. Effects of rocaglates on eIF4E phosphorylation in Mnk1+/+Mnk2+/+ and Mnk1−/−Mnk2−/− cells. Cells were incubated in the presence of the indicated compounds for two hours, lysed, fractionated on a 10% polyacrylamide gel, and transferred to PVDF membranes for western blotting. Blots were probed with antibodies directed to the proteins indicated to the right of the panel. GAPDH levels were used as an internal standard to account for variations in extract levels between lanes. Note that lane 24 is slightly underloaded based on the GAPDH internal standard.

References

    1. Ebada SS, Lajkiewicz N, Porco JA, Jr, Li-Weber M, Proksch P. Chemistry and biology of rocaglamides (= flavaglines) and related derivatives from aglaia species (meliaceae) Prog Chem Org Nat Prod. 2011;94:1–58. - PMC - PubMed
    1. Cencic R, Carrier M, Galicia-Vazquez G, Bordeleau ME, Sukarieh R, Bourdeau A, et al. Antitumor activity and mechanism of action of the cyclopenta[b]benzofuran, silvestrol. PLoS One. 2009;4:e5223. - PMC - PubMed
    1. Lucas DM, Edwards RB, Lozanski G, West DA, Shin JD, Vargo MA, et al. The novel plant-derived agent silvestrol has B-cell selective activity in chronic lymphocytic leukemia and acute lymphoblastic leukemia in vitro and in vivo. Blood. 2009;113:4656–66. - PMC - PubMed
    1. Alachkar H, Santhanam R, Harb JG, Lucas DM, Oaks JJ, Hickey CJ, et al. Silvestrol exhibits significant in vivo and in vitro antileukemic activities and inhibits FLT3 and miR-155 expressions in acute myeloid leukemia. Journal of hematology & oncology. 2013;6:21. - PMC - PubMed
    1. Bordeleau ME, Robert F, Gerard B, Lindqvist L, Chen SM, Wendel HG, et al. Therapeutic suppression of translation initiation modulates chemosensitivity in a mouse lymphoma model. J Clin Invest. 2008;118:2651–60. - PMC - PubMed

Publication types

MeSH terms